SkyCell launches next gen 1500X pharma container

Photo: SkyCell

SkyCell has launched its next generation 1500X container for high value pharmaceutical transport.

The 1500X is designed for pharma product shipments that need to be kept within +2°C to +8°C or +15°C to +25°C temperature ranges and has a tested independent runtime of 270 hours at 20°C.

The manufacturer of temperature-controlled hybrid containers said that the 1500X comes fully equipped with its proprietary SECURE SaaS platform for in-transit monitoring.

Manufactured with a die-cast frame using the same technique in the construction of aeroplane parts, the 1500X is 120kg lighter than its predecessor but still maintains a payload capacity of up to 1,000kg.

The new internal height of 1.3 m– creating 7.8% more internal volume – allows customers to transport more in each individual container, reducing costs and CO2 emissions.

The 270-hour runtime ensures that the transportation of temperature-sensitive goods remains unaffected even in the event of unforeseen circumstances such as flight delays, re-routing, and delays at customs.

The 1500X continues to feature SkyCell’s patented double-door system to prevent humidity changes and provide added security during transit. 

SkyCell’s SECURE offers real-time visibility of shipments, closing supply chain visibility gaps and allowing corrective actions to be made via critical data gathered during transportation.

SkyCell added that the 1500X “builds on years of design and manufacturing innovation that has led SkyCell’s containers to have a verified temperature excursion rate of less than 0.1% and a product loss rate of 0.0%”.

Four 1500X containers can be loaded onto one standard PMC pallet, while only a pallet jack is required to load the 1500X into a standard truck that can hold up to 18 containers.

The 1500X’s feet have been redesigned to improve shock and vibration protection. The die-cast aluminium feet absorb impact and dampen the vibrations from aircraft and trucks that are – along with excursions outside optimal temperature range – a leading cause of in-transit product spoilage.

Nico Ros, chief technology officer and co-founder of SkyCell, said that the 1500X development goals were based on the input from customers and helps them to reduce their CO2 footprint.

Ros stated: “Technical innovations like using graphene as part of our patented heat distribution enhance the 1500X’s recharge capability when in a cold room at customs clearance or in a reefer truck, protecting pharma products even longer, and demonstrating our ability to truly push the limits of smart design.”

Richard Ettl, chief executive officer and co-founder of SkyCell, said: “The 1500X delivers extra performance, extra protection, and extra efficiency.

He added: “SkyCell SECURE – acts like a ‘guardian angel’ by continuously monitoring the 1500X and helps to track its milestones to alert for delays or risks in the supply chain. The 1500X will help us continue to deliver on our vision to create no loss in the pharma supply chain, worldwide.”

Share this story

Related Topics

Latest pharma logistics news

Menzies secures CEIV pharma at Schiphol facility

Ground handler Menzies Aviation has been awarded the IATA CEIV Pharma accreditation for its cargo facility at Amsterdam Airport Schiphol…

Read More

Share this story

Tower Cold Chain offers Evolution in pharma shipping

Passive temperature-controlled container supplier Tower Cold Chain has developed an ultra-lightweight product compatible with US and EU pallets. The Evolution…

Read More

Share this story

UPS completes acquisition of MNX

In late September, Air Cargo News (ACN) reported on express services giant UPS acquiring time-critical logistics services provider MNX Global…

Read More

Share this story